These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 963476)

  • 21. Haemorrhagic cystitis due to gentian violet.
    Walsh C; Walsh A
    Br Med J (Clin Res Ed); 1986 Sep; 293(6549):732. PubMed ID: 3094630
    [No Abstract]   [Full Text] [Related]  

  • 22. Occlusive laryngotracheitis in turkeys following drinking water administration of gentian violet.
    Clark FD; Frame DD; Jensen MM
    Avian Dis; 1993; 37(1):226-8. PubMed ID: 8452501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible hazard in use of gentian violet.
    Rosenkranz HS; Carr HS
    Br Med J; 1971 Sep; 3(5776):702-3. PubMed ID: 5569557
    [No Abstract]   [Full Text] [Related]  

  • 24. Keratoconjunctivitis sicca following instillation of gentian violet.
    Dhir SP; Sharma SK; Munjal VP; Gupa A
    Indian J Ophthalmol; 1982 Jan; 30(1):21-22. PubMed ID: 7141584
    [No Abstract]   [Full Text] [Related]  

  • 25. [Generalized reactions (cyanosis, cardiovascular collapse) caused by sensitization to an aqueous solution of gentian violet and methyl green applied locally].
    MICHEL PJ; BUYER R; DELORME
    Bull Soc Fr Dermatol Syphiligr; 1958; 65(2):183. PubMed ID: 13573078
    [No Abstract]   [Full Text] [Related]  

  • 26. Accidents of a general nature (cyanosis, cardiovascular collapse) caused by sensitization to aqueous solution of gentian violet & methyl green in local administration.
    MICHEL PJ; BUYER R; DELORME
    Lyon Med; 1958 Nov; 90(46):798-9. PubMed ID: 13612300
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of the umbilicus with crystal violet solution.
    Bale MS
    Can Med Assoc J; 1981 Feb; 124(4):372-3. PubMed ID: 7214266
    [No Abstract]   [Full Text] [Related]  

  • 28. Irritative contact dermatitis due to gentian violet (methylrosaniline chloride) in an airplane passenger: a case report.
    Torres JA; Sastre J; De las Heras M; Requena L; del Haro R; Cazorla A
    J Investig Allergol Clin Immunol; 2009; 19(1):67-8. PubMed ID: 19274935
    [No Abstract]   [Full Text] [Related]  

  • 29. Gentian violet keratoconjunctivitis.
    Parker WT; Binder PS
    Am J Ophthalmol; 1979 Mar; 87(3):340-3. PubMed ID: 434094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrotic skin reactions caused by 1 per cent gentian violet and brilliant green.
    Björnberg A; Mobacken H
    Acta Derm Venereol; 1972; 52(1):55-60. PubMed ID: 4111108
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical gentian violet in dermatology.
    Bunker CB
    J Am Acad Dermatol; 2009 Feb; 60(2):347-8. PubMed ID: 19150283
    [No Abstract]   [Full Text] [Related]  

  • 32. [Necroses following the use of Pyoktanin].
    Sommer G; Happle R
    Hautarzt; 1977 Feb; 28(2):92-3. PubMed ID: 845034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Response to letter to the editor 23(1): 53, 1990: Risk of cancer development in recipients of gentian violet-treated blood. Validity of the interview].
    Luquetti AO
    Rev Soc Bras Med Trop; 1990; 23(4):237-8. PubMed ID: 2133593
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of methylrosaniline (gentian violet) to treat candidiasis].
    Swart EL; van der Waal I
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):688. PubMed ID: 15106322
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution.
    Safranek TJ; Jarvis WR; Carson LA; Cusick LB; Bland LA; Swenson JM; Silcox VA
    N Engl J Med; 1987 Jul; 317(4):197-201. PubMed ID: 3600710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of eye injury caused by methyl violet].
    SRZEDNICKA-CHRZANOWSKA K
    Klin Oczna; 1958; 28(2):165-8. PubMed ID: 13550728
    [No Abstract]   [Full Text] [Related]  

  • 37. Gentian violet is safe.
    Arbiser JL
    J Am Acad Dermatol; 2009 Aug; 61(2):359. PubMed ID: 19615548
    [No Abstract]   [Full Text] [Related]  

  • 38. The metabolism and mode of action of gentian violet.
    Docampo R; Moreno SN
    Drug Metab Rev; 1990; 22(2-3):161-78. PubMed ID: 2272286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy of oral hairy leukoplakia with gentian violet.
    Bhandarkar SS; MacKelfresh J; Fried L; Arbiser JL
    J Am Acad Dermatol; 2008 Apr; 58(4):711-2. PubMed ID: 18342722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ampliative medicament allergy: concomitant sensitivity to multiple medicaments including yellow soft paraffin, white soft paraffin, gentian violet and Span 20.
    Lawrence CM; Smith AG
    Contact Dermatitis; 1982 Jul; 8(4):240-5. PubMed ID: 7105686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.